Searched for
RUNJHUN JAIN
Ethos IPO sails through on the last day of biddingThe issue opened for subscription on Wednesday. The company is aiming to raise Rs 472.29 crore by selling its shares in the range of Rs 836...- Ethos IPO subscribed 30% on day 2; should you bid for the issue at 95x PE?The company and its shareholders plan to raise Rs 472 crore from the primary market. The issue consists of issuance of fresh equity shares ...
- Ethos IPO subscribed 13% so far on Day 1Ahead of the IPO, the company garnered Rs 141.69 crore from nine anchor investors. The company informed the exchanges that it has allocated...
- Gland Pharma up 40% in 2 days, but nobody can explain this sudden interestRunjhun Jain, a pharma analyst from Nirmal Bang, said the surge could only be a short-term phenomenon. That said, it is a good company for ...
- Smallcap pick of Kedia, Kacholia doubled money in last six monthsThe change in business strategy helped the stock rally over 135 per cent in last six months to trade at Rs 1,880 on September 30. Analysts ...
- API makers surge up to 110% in 50 days as virus hits Chinese exportsBrokerage sees coronavirus crisis as a positive for companies like Granules India and Natco.
- Dishman Pharma zooms 20% as merger with arms becomes effectiveFollowing the announcement, the stock hit its upper circuit limit of 20 per cent at Rs 278.20 on BSE.
- Splendid show: Hrudayalaya rises 35% on listing; good long-term betNarayana Hrudayalaya, the first debutant of Calendar 2016 in the stock market, got off to a splendid start on Wednesday.
- Maturing business, low attrition make Narayana Hrudayalaya a good long-term bet: Runjhun JainNarayana's hospitals, which are maturing or which are more than five years old, have Ebitda margins as high as 24%, says Jain.
- Man behind Vodafone's Zoozoo & PugFor clients such as Vodafone - for whom Rao played a key role in creating the Zoozoos and the “pug ads” - he’s their 'Michelangelo'.
Load More
